DI ROCCO, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 127
NA - Nord America 72
AS - Asia 71
SA - Sud America 3
Totale 273
Nazione #
IT - Italia 76
US - Stati Uniti d'America 69
SG - Singapore 22
GB - Regno Unito 15
IN - India 14
IR - Iran 8
TR - Turchia 8
SE - Svezia 7
CH - Svizzera 6
ID - Indonesia 6
CN - Cina 5
IE - Irlanda 4
IL - Israele 4
JP - Giappone 4
LT - Lituania 4
CA - Canada 3
CZ - Repubblica Ceca 3
BG - Bulgaria 2
BO - Bolivia 2
DE - Germania 2
FR - Francia 2
GR - Grecia 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
FI - Finlandia 1
Totale 273
Città #
Rome 41
Leeds 11
Singapore 11
Ankara 8
Mumbai 8
Jakarta 6
Milan 5
Dublin 4
Millbury 4
Princeton 4
Rishon LeTsiyyon 4
Vilnius 4
Houston 3
Los Angeles 3
Santa Clara 3
Tokyo 3
Toronto 3
Verona 3
Woodbridge 3
Ann Arbor 2
Ashburn 2
Bari 2
Boardman 2
Bordeaux 2
Brno 2
Cassino 2
Chicago 2
Fiumicino 2
Foggia 2
Geneva 2
Karystos 2
Lausanne 2
Lawrence 2
Nagpur 2
Oxford 2
San Diego 2
Santa Cruz 2
Sofia 2
Wilmington 2
Zurich 2
Andover 1
Bacoli 1
Beijing 1
Brussels 1
Bühl 1
Cambridge 1
Chandler 1
Chieti 1
Fairfield 1
Federal 1
Frankfurt am Main 1
Genzano di Roma 1
Jönköping 1
Karibacho 1
Lappeenranta 1
Pontecorvo 1
Redwood City 1
Seattle 1
Torre del Greco 1
Turin 1
Vigonza 1
Totale 194
Nome #
Functional characterization of novel germline mutations affecting CDC42 highlighted their differential impact on multiple signaling pathways. 47
Phenotypic Assessment of Pathogenic Variants in GNAO1 and Response to Caffeine in C. elegans Models of the Disease 34
Novel de novo CDC42 variants cause variable functional alterations and heterogeneous spectrum of neurodevelopmental and immune-hematologic rare diseases 32
Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia 28
The recurrent pathogenic Pro890Leu substitution in CLTC causes a generalized defect in synaptic transmission in Caenorhabditis elegans 27
null 27
Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders 22
C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples 21
De novo mutations involving the C-terminal tail of CDC42 cause distinct dyshematopoietic and autoinflammatory disorders 20
Functional variability of novel CDC42 pathogenic variants is associated with phenotypic heterogeneity of neurodevelopmental and immune-hematologic related disorders 18
GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments 17
Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling 16
Totale 309
Categoria #
all - tutte 1.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 7 1 0 0 0 0
2020/20218 0 0 0 0 1 2 0 0 0 0 0 5
2021/202251 2 0 1 0 2 3 1 2 16 2 8 14
2022/202344 7 3 0 1 6 5 4 4 10 1 1 2
2023/2024151 3 8 11 29 27 8 8 7 8 13 12 17
2024/202547 6 10 18 13 0 0 0 0 0 0 0 0
Totale 309